155 related articles for article (PubMed ID: 22300798)
1. Economic analysis of the use of facemasks during pandemic (H1N1) 2009.
Tracht SM; Del Valle SY; Edwards BK
J Theor Biol; 2012 May; 300():161-72. PubMed ID: 22300798
[TBL] [Abstract][Full Text] [Related]
2. Mathematical modeling of the effectiveness of facemasks in reducing the spread of novel influenza A (H1N1).
Tracht SM; Del Valle SY; Hyman JM
PLoS One; 2010 Feb; 5(2):e9018. PubMed ID: 20161764
[TBL] [Abstract][Full Text] [Related]
3. Excess influenza hospital admissions and costs due to the 2009 H1N1 pandemic in England.
Lau K; Hauck K; Miraldo M
Health Econ; 2019 Feb; 28(2):175-188. PubMed ID: 30338588
[TBL] [Abstract][Full Text] [Related]
4. The economic burden of the 2009 pandemic H1N1 influenza in Korea.
Kim YW; Yoon SJ; Oh IH
Scand J Infect Dis; 2013 May; 45(5):390-6. PubMed ID: 23240778
[TBL] [Abstract][Full Text] [Related]
5. The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.
Milne GJ; Halder N; Kelso JK
PLoS One; 2013; 8(4):e61504. PubMed ID: 23585906
[TBL] [Abstract][Full Text] [Related]
6. Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics.
Halder N; Kelso JK; Milne GJ
PLoS One; 2011; 6(7):e22087. PubMed ID: 21760957
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
[TBL] [Abstract][Full Text] [Related]
8. Influence of asymptomatic infections for the effectiveness of facemasks during pandemic influenza.
Cui J; Zhang Y; Feng ZL; Guo SB; Zhang Y
Math Biosci Eng; 2019 May; 16(5):3936-3946. PubMed ID: 31499643
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics.
Pérez Velasco R; Praditsitthikorn N; Wichmann K; Mohara A; Kotirum S; Tantivess S; Vallenas C; Harmanci H; Teerawattananon Y
PLoS One; 2012; 7(2):e30333. PubMed ID: 22393352
[TBL] [Abstract][Full Text] [Related]
10. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.
Kelso JK; Halder N; Postma MJ; Milne GJ
BMC Public Health; 2013 Mar; 13():211. PubMed ID: 23496898
[TBL] [Abstract][Full Text] [Related]
11. Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.
Pasquini-Descomps H; Brender N; Maradan D
Value Health; 2017 Jun; 20(6):819-827. PubMed ID: 28577700
[TBL] [Abstract][Full Text] [Related]
12. Modeling the economic impact of pandemic influenza: a case study in Turkey.
Yoldascan E; Kurtaran B; Koyuncu M; Koyuncu E
J Med Syst; 2010 Apr; 34(2):139-45. PubMed ID: 20433052
[TBL] [Abstract][Full Text] [Related]
13. Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.
Chowell G; Viboud C; Simonsen L; Miller MA; Echevarría-Zuno S; González-León M; Aburto VH
BMC Infect Dis; 2012 Apr; 12():97. PubMed ID: 22520743
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic factors influencing hospitalized patients with pneumonia due to influenza A(H1N1)pdm09 in Mexico.
Manabe T; Higuera Iglesias AL; Vazquez Manriquez ME; Martinez Valadez EL; Ramos LA; Izumi S; Takasaki J; Kudo K
PLoS One; 2012; 7(7):e40529. PubMed ID: 22808184
[TBL] [Abstract][Full Text] [Related]
15. Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.
Borse RH; Shrestha SS; Fiore AE; Atkins CY; Singleton JA; Furlow C; Meltzer MI
Emerg Infect Dis; 2013 Mar; 19(3):439-48. PubMed ID: 23622679
[TBL] [Abstract][Full Text] [Related]
16. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania.
Brown ST; Tai JH; Bailey RR; Cooley PC; Wheaton WD; Potter MA; Voorhees RE; LeJeune M; Grefenstette JJ; Burke DS; McGlone SM; Lee BY
BMC Public Health; 2011 May; 11():353. PubMed ID: 21599920
[TBL] [Abstract][Full Text] [Related]
17. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.
Fowlkes A; Steffens A; Temte J; Lonardo SD; McHugh L; Martin K; Rubino H; Feist M; Davis C; Selzer C; Lojo J; Oni O; Kurkjian K; Thomas A; Boulton R; Bryan N; Lynfield R; Biggerstaff M; Finelli L;
Lancet Respir Med; 2015 Sep; 3(9):709-718. PubMed ID: 26300111
[TBL] [Abstract][Full Text] [Related]
18. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic.
Lemaitre M; Carrat F; Rey G; Miller M; Simonsen L; Viboud C
PLoS One; 2012; 7(9):e45051. PubMed ID: 23028756
[TBL] [Abstract][Full Text] [Related]
19. School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.
Basurto-Dávila R; Meltzer MI; Mills DA; Beeler Asay GR; Cho BH; Graitcer SB; Dube NL; Thompson MG; Patel SA; Peasah SK; Ferdinands JM; Gargiullo P; Messonnier M; Shay DK
Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2307-2330. PubMed ID: 29130266
[TBL] [Abstract][Full Text] [Related]
20. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
